Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × copanlisib × 90 days × Clear all

Sponsor

Conditions

Lymphoma 3 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Malignant Solid Neoplasm 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Fallopian Tube Neoplasms 1 Disease Progression 1

Interventions

Specimen Handling 7 Biopsy 6 fludarabine 3 ruxolitinib 2 decitabine and cedazuridine drug combination 2 Tacrolimus 2 Injections 2 Decitabine 2 Cyclophosphamide 2 Busulfan 2 Azacitidine 2 venetoclax 1 veliparib 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 fludarabine phosphate 1 fedratinib 1 axatilimab 1 Topotecan 1 Thiotepa 1 Succimer 1 Stem Cell Transplantation 1 Pentetic Acid 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡